MedPath
HSA Approval

SUNTOTIFEN SYRUP 1 mg/5 ml

SIN08053P

SUNTOTIFEN SYRUP 1 mg/5 ml

SUNTOTIFEN SYRUP 1 mg/5 ml

February 28, 1995

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R06AX17

ketotifen

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

KETOTIFEN FUMARATE EQV KETOTIFEN

1 mg/5 ml

Ketotifen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SUNTOTIFEN SYRUP 1 mg/5 ml - HSA Approval | MedPath